A Collection of Bioactive Nitrogen-Containing Molecules from the Marine Sponge <i>Acanthostrongylophora ingens</i>
Germana Esposito,
Linh H. Mai,
Arlette Longeon,
Alfonso Mangoni,
Emilie Durieu,
Laurent Meijer,
Rob Van Soest,
Valeria Costantino,
Marie-Lise Bourguet-Kondracki
Affiliations
Germana Esposito
The Blue Chemistry Lab, Department of Pharmacy, University of Naples Federico II, 80138 Napoli, Italy
Linh H. Mai
Laboratoire Molécules de Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, Muséum National d’Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, France
Arlette Longeon
Laboratoire Molécules de Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, Muséum National d’Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, France
Alfonso Mangoni
The Blue Chemistry Lab, Department of Pharmacy, University of Naples Federico II, 80138 Napoli, Italy
Emilie Durieu
ManRos Therapeutics, Perharidy Peninsula, 29680 Roscoff, France
Laurent Meijer
ManRos Therapeutics, Perharidy Peninsula, 29680 Roscoff, France
Rob Van Soest
Naturalis Biodiversity Center, P.O. Box 9517, 2300 RA Leiden, The Netherlands
Valeria Costantino
The Blue Chemistry Lab, Department of Pharmacy, University of Naples Federico II, 80138 Napoli, Italy
Marie-Lise Bourguet-Kondracki
Laboratoire Molécules de Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, Muséum National d’Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, France
Thirteen nitrogen-containing molecules (1a/1b and 2−12) were isolated from the Indonesian sponge Acanthostrongylophora ingens, highlighting the richness of this organism as a source of alkaloids. Their structures were elucidated using one- and two-dimensional NMR spectroscopy and HR-ESI-MS, while the stereochemistry of the diketopiperazines was established using Marfey’s method. All compounds were screened in our standard bioactivity assays, including antibacterial, antikinases, and amyloid β-42 assays. The most interesting bioactivity result was obtained with the known acanthocyclamine A (3), which revealed for the first time a specific Escherichia coli antimicrobial activity and an inhibitory effect on amyloid β-42 production induced by aftin-5 and no cytotoxicity at the dose of 26 µM. These results highlight the potentiality of a bipiperidine scaffold as a promising skeleton for preventing or reducing the production of amyloid β-42, a key player in the initiation of Alzheimer’s disease.